{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:06:44Z","timestamp":1775714804939,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We report a case of subacute cerebellar infarction mimicking metastasis on prostate-specific membrane antigen (PSMA) PET\/CT. A 77-year-old man with prostate cancer treated with androgen deprivation therapy and radiotherapy with rising prostate-specific antigen was referred for <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT. Apart from PSMA-expressing tumor of the left prostate, PSMA PET\/CT demonstrated radiotracer uptake in the right cerebellar hemisphere, corresponding to a site of subacute infarction demonstrated on an MRI of the brain performed 35 days previously. As cerebellar infarcts are considerably less common than cerebral infarcts, they may not be anticipated as a potential cause for false-positive radiotracer uptake on PSMA PET.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001948","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T03:00:02Z","timestamp":1513825202000},"page":"134-135","source":"Crossref","is-referenced-by-count":12,"title":["Subacute Cerebellar Infarction With Uptake on 68Ga\u2013Prostate-Specific Membrane Antigen PET\/CT"],"prefix":"10.1097","volume":"43","author":[{"given":"Geon","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RLU.0000000000000709","article-title":"Detection of brain metastasis with 68Ga-labeled PSMA ligand PET\/CT: a novel radiotracer for imaging of prostate carcinoma","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RLU.0000000000001526","article-title":"Cerebellar metastases from prostate cancer on 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-3919.198450","article-title":"Rare sites of metastases in prostate cancer detected on Ga-68 PSMA PET\/CT scan\u2014a case series","volume":"32","year":"2017","journal-title":"Indian J Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1097\/RLU.0000000000001291","article-title":"Subacute stroke mimicking cerebral metastasis in 68Ga-PSMA-HBED-CC PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/RLU.0000000000001489","article-title":"Subacute cortical infarct showing uptake on 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.STR.18.5.849","article-title":"Cerebellar infarction: natural history, prognosis and pathology","volume":"18","year":"1987","journal-title":"Stroke"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/01.STR.24.11.1697","article-title":"Cerebellar infarction. Clinical and neuroimaging analysis in 293 patients. The Tohoku Cerebellar Infarction Study Group","volume":"24","year":"1993","journal-title":"Stroke"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/RLU.0000000000001451","article-title":"Diagnostic value of 68Ga PSMA-11 PET\/CT imaging of brain tumors\u2014preliminary analysis","volume":"42","year":"2017","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201802000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:02:29Z","timestamp":1695618149000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201802000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001948","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}